News

Hexoskin Selected for the Inaugural Mayo Clinic and ASU MedTech Accelerator

Our team is excited to announce that Hexoskin is one of only six medical technology companies selected by the Mayo Clinic and Arizona State University (ASU) for its inaugural MedTech Accelerator cohort. The accelerator, which is part of the Mayo Clinic Arizona State University Alliance for Health Care, was designed specifically for medical device and health care technology companies looking to partner with Mayo Clinic and ASU.

"The inaugural cohort of the program consists of six extremely dynamic startups with product offerings we feel are poised to improve patient care and outcomes through their new innovations," says Steven Lester, M.D., a Mayo Clinic cardiologist and medical director of the accelerator. Dr. Lester, professor of Medicine, is also associate medical director of Mayo Clinic's Department of Business Development.

"At Hexoskin we see a great fit between our vision for at-home patient monitoring, post-acute care, and chronic disease management and Mayo Clinic's mission to put the best interest of the patient first." says Pierre-Alexandre Fournier, MScA, Co-founder and CEO of Hexoskin.

Hexoskin provides a seamless integration of its smart shirts for vital signs monitoring with hospitals’ existing processes to improve upon the patient experience. The accelerator program gives Hexoskin the opportunity to collaborate with the country’s most distinguished medical mentors and researchers and develop new clinical opportunities for Hexoskin technology. 


About Hexoskin

Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Sourcehttps://newsnetwork.mayoclinic.org/discussion/mayo-clinic-asu-select-six-startups-for-inaugural-medtech-accelerator-cohort/

 

FC Barcelona - Barça Innovation Hub (BIHub) and Allianz align themselves to promote a study on sleep and young athletes

Hexoskin is very proud to be part of this study on sleep and young athletes with FC Barcelona, a world leader in the development of young athletes, and Allianz, one of the world's largest insurers.

Hexoskin has been involved in sleep research since 2012. We share the views of FC Barcelona that we need to do more research on sleep and young athletes to optimize their health and their gameplay. There's more than one way to monitor sleep with Hexoskin smart shirts, and this study allows us to advance of our knowledge of sleep in teenage athletes.

"The information gathered will be processed by doctors at the Adsalutem Institute, and FC Barcelona will provide data on the performance of the analysed athletes to be cross-referenced with those obtained on the quality of their sleep. A study will be shared detailing the conclusions obtained. The Adsalutem Institute has the academic support of the Universitat Internacional de Catalunya (UIC) within the framework of the 'Center for Studies of Sleep Medicine', in which both entities collaborate in the scientific and teaching fields."

 

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Source: https://www.fcbarcelona.com/en/club/news/1111799/the-bihub-and-allianz-align-themselves-to-promote-a-study-on-sleep#

Hexoskin Application Programming Interface (API) Update

We've done important improvements to the platform over the past year. We've improved the speed of many frequently used functions, and added security and privacy measures that will benefit both developers and users. Some of the improvements mean we'll bring down older versions of the Hexoskin API, including versions supporting OAuth 1.0. That means all authentication will need to be made using OAuth 2.0 starting in April. 

The current Hexoskin API version is 4.5.0.*

*API versions older than 4.0.0 will be retired on Wednesday April 10th, 2019 12PM EDT.

We invite you to go to our Developer page to learn more about developer tools and documentation. For more information, please contact the Hexoskin API team: api@hexoskin.com

About Hexoskin
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Government of Canada confirmed Canada's commitment to Nasa Lunar Gateway program

The government of Canada confirmed today, Thursday, February 28, 2019, Canada's commitment to the Lunar Gateway space mission led by the United States, to give Canada's space program a new momentum. The Prime Minister of Canada Justin Trudeau announced historic investments in Canada’s space program. The Government of Canada will invest $2.05 billion over 24 years for Canada's space program. It will help grow innovative Canadian companies of all sizes by supporting the development of new digital and artificial intelligence-based technologies, and by opening new markets for Canadian businesses (Prime Minister's Office).

This investment will also give Canadian astronauts the opportunity to participate in missions to space and our scientists a chance to conduct cutting-edge research that cannot be done on Earth.

At Hexoskin, since we started working with Canadian Space Agency in 2011, we designed medical monitoring systems with the goal of fulfilling the autonomy requirements of future missions to the Moon and Mars. The spillover effects of space exploration projects are applicable beyond human spaceflight and find applications on earth that benefit humanity.

The technologies we're developing will allow a greater number of people to access regular care, especially patients with chronic cardiovascular and respiratory diseases. The software being developed for medical autonomous systems has the potential to deliver automated health services, affordable and accessible 24/7.

After today's announcement, we hope that Hexoskin will be able to contribute to future missions to the Moon, by supplying innovative medical technologies for crew members taking the trip.

 

Live Webinar - Join Us for the upcoming Hexoskin Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin



Join Us for our Hexoskin Live Webinar on February 27th! 

We invite you to attend our Live Webinar on Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin, that will cover the latest fields of applications & research studies. Our guest speaker, Thomas Beltrame, PhD, will discuss his work with his fellow research team at University of Waterloo to evaluate cardiovascular & respiratory health with Hexoskin and machine learning.

We will also present how the Hexoskin and Astroskin end-to-end platforms can support research and professional organizations for their Machine Learning & Artificial Intelligence projects.

HEXOSKIN LIVE WEBINAR:
Artificial Intelligence, Cardiovascular & Respiratory Health Research with Hexoskin
Wednesday, February 27, 2019, at 12:00 PM (EST) - via the Zoom Video Conferencing software

Speakers: 
Pierre-Alexandre Fournier
CEO & Co-Founder, Hexoskin

Thu Ngan Trinh PhD
Clinical Applications Specialist, Hexoskin

Guest Speaker: 
Thomas Beltrame PhD
Department of Physiotherapy - Federal University of São Carlos
Institute of Computing - University of Campinas

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!

Deployment of the Bio-Monitor in Space by Canadian Space Agency Astronaut David Saint-Jacques (CSA)

This week, Canadian Space Agency Astronaut David Saint-Jacques deployed and tested for the first time in space a new Canadian technology: the Bio-Monitor System.

This advanced smart shirt is designed to measure and record vital signs in microgravity environment. It will help keep an eye on astronauts' health and enable medical research in space by continuously measuring physiological data.

The Canadian Space Agency's Bio-Monitor is designed to easily send information to the ground, where scientists can monitor astronauts' physiology around the clock as they orbit the planet. Once operational it will be available for the next five years to all participating countries to the International Space Station.

To learn more: http://asc-csa.gc.ca/eng/missions/expedition58/default.asp.
Photo: CSA/NASA

 

December 05, 2018

Astroskin › Conventions & Events › space ›


Astroskin / Bio-Monitor Successfully Launched to Space aboard Space X Dragon Spacecraft

Launch successful! En route to the International Space Station! The Bio-Monitor Astroskin system is part of the payload that was launched today in a Dragon spacecraft on a Falcon 9 rocket from Cape Canaveral, Florida.



About Hexoskin
Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space. To learn more on Astroskin Vital Signs Monitoring Platform download Astroskin Product Specifications document. 
Contact our team to order Astroskin

Live Webcast - Join Us for the Bio-Monitor (Astroskin) launch to Space on December 4th!

We are happy to invite you to our live webcast on December 4th, that will broadcast the Astroskin launch to Space aboard Space X Dragon Cargo vehicle. Before the launch, Hexoskin's co-founders will discuss the history of the development of the Bio-Monitor system as well as a few case applications in Space and on Earth.

The Astroskin system is based on the Bio-Monitor designed for the Canadian Space Agency (CSA) to monitor the astronauts’ health in space on the International Space Station (ISS). It will be operational in space and available for all ISS participating countries to conduct space research for the next five years.
 
LIVE WEBCAST:
Astroskin Launch to the ISS aboard SpaceX Dragon Cargo
December 4, 2018, at 1:25 PM (EST)** - via the Zoom Video Conferencing software
** In case of postponement of the launch, you will receive a notification
with a new broadcast schedule.

Speakers: 
- Pierre-Alexandre Fournier, CEO & Co-Founder, Hexoskin
- Jean-François Roy, CTO & Co-Founder, Hexoskin 


Guest Speaker: 
- Professor Richard L. Hughson Ph.D., University of Waterloo

If you are unable to attend, you can still register and we will send you the recorded webcast by email afterward. 

We look forward to your presence for this special event!



About Hexoskin

Since 2006, Hexoskin’s mission is to develop sensors and health data infrastructure to generate clinical grade real-world evidence. The Astroskin demonstrates once again Hexoskin’s leadership in providing the industry leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.

Contact our team to order Astroskin

November 21, 2018

products › User Experience ›


Introducing the New Hexoskin Dashboard

We are introducing a new Dashboard to improve your experience with Hexoskin. You can now monitor your health closely, share your data or manage groups of users efficiently with advanced functionalities requested by our user community.

This dashboard completes our ever-evolving Hexoskin Connected Health Platform. Here are a few features that you should try today!

The Bio-Monitor to launch to the International Space Station

The Bio-Monitor, designed by Hexoskin for the Canadian Space Agency (CSA) to monitor the Astronauts' Health in Space aboard the International Space Station (ISS) is finally launching to Space! The Bio-Monitor System is scheduled to launch aboard a SpaceX Dragon cargo spacecraft on December 4, 2018, at Cape Canaveral Air Force Station in Florida.

David Saint-Jacques will be the next Canadian astronaut to live in the ISS. His first mission to the ISS is scheduled to launch on December 3, 2018David Saint-Jacques will be conducting tests and experiments with the Bio-Monitor platform.

Last week, the Canadian Space Agency announced the award of an additional contract to Carré Technologies (Hexoskin). The Hexoskin team is excited to continue an adventure that started in 2011 with the Canadian Space Agency and wishes the best of luck the astronaut David Saint-Jacques for his mission.

Learn more at:
http://www.asc-csa.gc.ca/eng/sciences/bio-monitor.asp

About Hexoskin:
Founded in 2006 in Montreal, Carré Technologies Inc. (Hexoskin) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.

Hexoskin’s provide solutions and services directly to customers & athletes; and through B2B contracts in security, defense & aerospace agencies, pharmaceutical companies, academics, and healthcare organizations. 

Hexoskin obtained its first contract from the Canadian Space Agency in October 2011. The Bio-Monitor demonstrates once again Hexoskin’s leadership in providing industry-leading sensors, software, and AI to push further our understanding of human physiology on earth and in space.  

In September 2018, Hexoskin launched the Astroskin Research Platform to support various projects and health research on earth. The Astroskin is based on the Bio-Monitor and is further adapted to be used on earth. Astroskin offers an end-to-end platform to collect real-world evidence with space-grade garments that include sensors embedded in the fabric such as a 3-lead electrocardiogram, breathing sensors, pulse oximeter, blood pressure, skin temperature, and activity sensors.

Contact us to order Astroskin for your project.

« Previous 1 7 8 9 10 11 19 Next »